2seventy bio is an American cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
2seventy bio news
13.05.2022
2seventy bio's GAAP loss for 3 months of 2022 was $85.711 million, down 1.7% from $87.196 million in the prior year. Revenue decreased 29.2% to $8.429 million from $11.901 million a year earlier.
Source: 
ir.2seventybio.com
ir.2seventybio.com
22.03.2022
2seventy bio's GAAP loss for 2021 was $292.213 million, up 2.4 times from $120.114 million in the previous year. Revenue declined 4.6 times to $54.522 million from $248.122 million a year earlier.
Source: ir.2seventybio.com
ir.2seventybio.com
01.12.2021
2seventy bio's GAAP loss for 9M 2021 was $231.237 mln, up 5.4 times from $43.313 mln in the previous year. 2021 was $231.237 million, up 5.4 times from $43.313 million in the previous year. Revenue declined 6.1 times to $38.488 million from $238.217 million a year earlier.
Source: ir.2seventybio.com
ir.2seventybio.com
General information
| Company name | 2seventy bio |
|---|---|
| Tags | #biotechnology, #cancer treatment |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology |
| Business address | 60 Binney Street Cambridge, MA 02142 United States |
| Mailing address | 60 Binney Street Cambridge, MA 02142 United States |
| Website | ir.2seventybio.com |
English (US) 